Related Experiment Video
Updated: Jul 5, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Urinary tract infections
Dimitri M Drekonja1, James R Johnson
1Minneapolis Veterans Affairs Medical Center, Infectious Diseases (111F), 1 Veterans Drive, Minneapolis, MN 55417, USA. drek0002@umn.edu
Abstract:
Urinary tract infection (UTI), with its diverse clinical syndromes and affected host groups, remains one of the most common but widely misunderstood and challenging infectious diseases encountered in clinical practice. Antimicrobial resistance is a leading concern, with few oral options available to treat infections caused by Gram-negative organisms resistant to trimethoprim-sulfamethoxazole and fluoroquinolones, especially for patients with upper tract disease. Efforts should be made not to detect or treat asymptomatic bacteriuria and funguria; to ensure an appropriate duration of therapy for symptomatic infections; and to limit the use of broad-spectrum agents, especially fluoroquinolones, if narrower spectrum agents are available. Further research is needed regarding rapid diagnosis of UTI, accurate presumptive identification of patients with resistant pathogens, and development of new antimicrobials for drug-resistant UTI.
Insights
Urinary tract infections (UTIs) are common and challenging. Antimicrobial resistance limits treatment options, necessitating careful antibiotic use and new drug development.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Urinary tract infections (UTIs) are prevalent yet often misunderstood infectious diseases.
- Antimicrobial resistance poses a significant challenge, particularly for Gram-negative UTIs resistant to common oral antibiotics.
- Limited oral treatment options exist for complicated UTIs and infections caused by resistant pathogens.
Purpose of the Study:
- To highlight the challenges in managing UTIs due to antimicrobial resistance.
- To emphasize appropriate diagnostic and treatment strategies for UTIs.
- To identify areas for future research in UTI management.
Main Methods:
- Review of current clinical practices and challenges in UTI management.
- Analysis of the impact of antimicrobial resistance on treatment efficacy.
- Identification of knowledge gaps and research needs.
Main Results:
- Antimicrobial resistance, especially to trimethoprim-sulfamethoxazole and fluoroquinolones, restricts effective oral therapy for UTIs.
- Asymptomatic bacteriuria and funguria should not be treated.
- Appropriate duration of therapy and judicious use of broad-spectrum agents are crucial.
Conclusions:
- Prudent antibiotic stewardship is essential for managing UTIs.
- Further research is required for rapid UTI diagnosis and development of novel antimicrobials.
- Addressing antimicrobial resistance is critical for improving UTI patient outcomes.
More Related Videos
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
07:34Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
Published on: April 16, 2019
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Disorders of the Urinary System
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
Microbiota of the Urogenital Tract